ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Cancer Therapeutics Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-11S13481
Home | Market Reports | Health| Health Conditions| Cancer
Global Kidney Cancer Therapeutics Market Research Report 2023
BUY CHAPTERS

Global Kidney Cancer Therapeutics Market Research Report 2025

Code: QYRE-Auto-11S13481
Report
March 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Novartis
Bristol–Myers Squibb
Pfizer Inc
Roche
Amgen Inc
AVEO Pharmaceuticals
Bayer
Exelixis Inc
Eisai Co Ltd

Kidney Cancer Therapeutics Market Size

The global market for Kidney Cancer Therapeutics was valued at US$ 452 million in the year 2024 and is projected to reach a revised size of US$ 585 million by 2031, growing at a CAGR of 3.8% during the forecast period.

Kidney Cancer Therapeutics Market

Kidney Cancer Therapeutics Market

Kidney cancer is cancer that begins in the kidneys. Your kidneys are two bean-shaped organs, each about the size of your fist. They"re located behind your abdominal organs, with one kidney on each side of your spine. In adults, renal cell carcinoma is the most common type of kidney cancer.
The kidney cancer therapeutics market is evolving rapidly to address the treatment needs of patients diagnosed with kidney cancer, also known as renal cell carcinoma (RCC). This market encompasses a range of therapies, including targeted therapies, immunotherapies, and combination treatments. The increasing incidence of kidney cancer, advancements in understanding its molecular basis, and the emergence of novel treatment options are driving market growth. Targeted therapies that inhibit specific pathways implicated in kidney cancer progression, along with immunotherapies that harness the immune system"s response, are gaining prominence. As research continues and personalized treatment approaches gain traction, the kidney cancer therapeutics market is expected to expand, offering new hope for improved outcomes and quality of life for patients with this challenging disease.
This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Therapeutics.
The Kidney Cancer Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Kidney Cancer Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kidney Cancer Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Kidney Cancer Therapeutics Market Report

Report Metric Details
Report Name Kidney Cancer Therapeutics Market
Accounted market size in year US$ 452 million
Forecasted market size in 2031 US$ 585 million
CAGR 3.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Kidney Cancer Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Kidney Cancer Therapeutics Market growing?

Ans: The Kidney Cancer Therapeutics Market witnessing a CAGR of 3.8% during the forecast period 2025-2031.

What is the Kidney Cancer Therapeutics Market size in 2031?

Ans: The Kidney Cancer Therapeutics Market size in 2031 will be US$ 585 million.

Who are the main players in the Kidney Cancer Therapeutics Market report?

Ans: The main players in the Kidney Cancer Therapeutics Market are Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai

What are the Application segmentation covered in the Kidney Cancer Therapeutics Market report?

Ans: The Applications covered in the Kidney Cancer Therapeutics Market report are Renal Cell Carcinoma, Renal Pelvis Cancer, Other

What are the Type segmentation covered in the Kidney Cancer Therapeutics Market report?

Ans: The Types covered in the Kidney Cancer Therapeutics Market report are Surgery, Immunotherapy, Targeted Therapy, Other

Recommended Reports

Kidney Disease Treatment

Cancer Therapeutic Drugs

Kidney Cancer Related

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Surgery
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Kidney Cancer Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Renal Cell Carcinoma
1.3.3 Renal Pelvis Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Therapeutics Market Perspective (2020-2031)
2.2 Global Kidney Cancer Therapeutics Growth Trends by Region
2.2.1 Global Kidney Cancer Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Kidney Cancer Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Kidney Cancer Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Kidney Cancer Therapeutics Market Dynamics
2.3.1 Kidney Cancer Therapeutics Industry Trends
2.3.2 Kidney Cancer Therapeutics Market Drivers
2.3.3 Kidney Cancer Therapeutics Market Challenges
2.3.4 Kidney Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Kidney Cancer Therapeutics Players by Revenue
3.1.1 Global Top Kidney Cancer Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Kidney Cancer Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Kidney Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Kidney Cancer Therapeutics Revenue
3.4 Global Kidney Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Kidney Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Therapeutics Revenue in 2024
3.5 Global Key Players of Kidney Cancer Therapeutics Head office and Area Served
3.6 Global Key Players of Kidney Cancer Therapeutics, Product and Application
3.7 Global Key Players of Kidney Cancer Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Therapeutics Breakdown Data by Type
4.1 Global Kidney Cancer Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Kidney Cancer Therapeutics Forecasted Market Size by Type (2026-2031)
5 Kidney Cancer Therapeutics Breakdown Data by Application
5.1 Global Kidney Cancer Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Kidney Cancer Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Kidney Cancer Therapeutics Market Size (2020-2031)
6.2 North America Kidney Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Kidney Cancer Therapeutics Market Size by Country (2020-2025)
6.4 North America Kidney Cancer Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Kidney Cancer Therapeutics Market Size (2020-2031)
7.2 Europe Kidney Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Kidney Cancer Therapeutics Market Size by Country (2020-2025)
7.4 Europe Kidney Cancer Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Kidney Cancer Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Kidney Cancer Therapeutics Market Size (2020-2031)
9.2 Latin America Kidney Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Kidney Cancer Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Kidney Cancer Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Kidney Cancer Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kidney Cancer Therapeutics Introduction
11.1.4 Merck Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Kidney Cancer Therapeutics Introduction
11.2.4 Novartis Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Kidney Cancer Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Kidney Cancer Therapeutics Introduction
11.4.4 Pfizer Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.4.5 Pfizer Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Kidney Cancer Therapeutics Introduction
11.5.4 Roche Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Kidney Cancer Therapeutics Introduction
11.6.4 Amgen Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Aveo Pharmaceuticals
11.7.1 Aveo Pharmaceuticals Company Details
11.7.2 Aveo Pharmaceuticals Business Overview
11.7.3 Aveo Pharmaceuticals Kidney Cancer Therapeutics Introduction
11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.7.5 Aveo Pharmaceuticals Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Kidney Cancer Therapeutics Introduction
11.8.4 Bayer Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.8.5 Bayer Recent Development
11.9 Exelixis
11.9.1 Exelixis Company Details
11.9.2 Exelixis Business Overview
11.9.3 Exelixis Kidney Cancer Therapeutics Introduction
11.9.4 Exelixis Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.9.5 Exelixis Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Kidney Cancer Therapeutics Introduction
11.10.4 Eisai Revenue in Kidney Cancer Therapeutics Business (2020-2025)
11.10.5 Eisai Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck
Novartis
Bristol–Myers Squibb
Pfizer Inc
Roche
Amgen Inc
AVEO Pharmaceuticals
Bayer
Exelixis Inc
Eisai Co Ltd
List of Tables
 Table 1. Global Kidney Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Surgery
 Table 3. Key Players of Immunotherapy
 Table 4. Key Players of Targeted Therapy
 Table 5. Key Players of Other
 Table 6. Global Kidney Cancer Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Kidney Cancer Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Kidney Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Kidney Cancer Therapeutics Market Share by Region (2020-2025)
 Table 10. Global Kidney Cancer Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Kidney Cancer Therapeutics Market Share by Region (2026-2031)
 Table 12. Kidney Cancer Therapeutics Market Trends
 Table 13. Kidney Cancer Therapeutics Market Drivers
 Table 14. Kidney Cancer Therapeutics Market Challenges
 Table 15. Kidney Cancer Therapeutics Market Restraints
 Table 16. Global Kidney Cancer Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Kidney Cancer Therapeutics Market Share by Players (2020-2025)
 Table 18. Global Top Kidney Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics as of 2024)
 Table 19. Ranking of Global Top Kidney Cancer Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Kidney Cancer Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Kidney Cancer Therapeutics, Headquarters and Area Served
 Table 22. Global Key Players of Kidney Cancer Therapeutics, Product and Application
 Table 23. Global Key Players of Kidney Cancer Therapeutics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Kidney Cancer Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Kidney Cancer Therapeutics Revenue Market Share by Type (2020-2025)
 Table 27. Global Kidney Cancer Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Kidney Cancer Therapeutics Revenue Market Share by Type (2026-2031)
 Table 29. Global Kidney Cancer Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Kidney Cancer Therapeutics Revenue Market Share by Application (2020-2025)
 Table 31. Global Kidney Cancer Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Kidney Cancer Therapeutics Revenue Market Share by Application (2026-2031)
 Table 33. North America Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Kidney Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Kidney Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Kidney Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Kidney Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Kidney Cancer Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Kidney Cancer Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Kidney Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Kidney Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Kidney Cancer Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Kidney Cancer Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Merck Company Details
 Table 49. Merck Business Overview
 Table 50. Merck Kidney Cancer Therapeutics Product
 Table 51. Merck Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 52. Merck Recent Development
 Table 53. Novartis Company Details
 Table 54. Novartis Business Overview
 Table 55. Novartis Kidney Cancer Therapeutics Product
 Table 56. Novartis Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 57. Novartis Recent Development
 Table 58. Bristol-Myers Squibb Company Details
 Table 59. Bristol-Myers Squibb Business Overview
 Table 60. Bristol-Myers Squibb Kidney Cancer Therapeutics Product
 Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 62. Bristol-Myers Squibb Recent Development
 Table 63. Pfizer Company Details
 Table 64. Pfizer Business Overview
 Table 65. Pfizer Kidney Cancer Therapeutics Product
 Table 66. Pfizer Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 67. Pfizer Recent Development
 Table 68. Roche Company Details
 Table 69. Roche Business Overview
 Table 70. Roche Kidney Cancer Therapeutics Product
 Table 71. Roche Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 72. Roche Recent Development
 Table 73. Amgen Company Details
 Table 74. Amgen Business Overview
 Table 75. Amgen Kidney Cancer Therapeutics Product
 Table 76. Amgen Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 77. Amgen Recent Development
 Table 78. Aveo Pharmaceuticals Company Details
 Table 79. Aveo Pharmaceuticals Business Overview
 Table 80. Aveo Pharmaceuticals Kidney Cancer Therapeutics Product
 Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 82. Aveo Pharmaceuticals Recent Development
 Table 83. Bayer Company Details
 Table 84. Bayer Business Overview
 Table 85. Bayer Kidney Cancer Therapeutics Product
 Table 86. Bayer Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 87. Bayer Recent Development
 Table 88. Exelixis Company Details
 Table 89. Exelixis Business Overview
 Table 90. Exelixis Kidney Cancer Therapeutics Product
 Table 91. Exelixis Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 92. Exelixis Recent Development
 Table 93. Eisai Company Details
 Table 94. Eisai Business Overview
 Table 95. Eisai Kidney Cancer Therapeutics Product
 Table 96. Eisai Revenue in Kidney Cancer Therapeutics Business (2020-2025) & (US$ Million)
 Table 97. Eisai Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Kidney Cancer Therapeutics Picture
 Figure 2. Global Kidney Cancer Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Kidney Cancer Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Surgery Features
 Figure 5. Immunotherapy Features
 Figure 6. Targeted Therapy Features
 Figure 7. Other Features
 Figure 8. Global Kidney Cancer Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Kidney Cancer Therapeutics Market Share by Application: 2024 VS 2031
 Figure 10. Renal Cell Carcinoma Case Studies
 Figure 11. Renal Pelvis Cancer Case Studies
 Figure 12. Other Case Studies
 Figure 13. Kidney Cancer Therapeutics Report Years Considered
 Figure 14. Global Kidney Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Kidney Cancer Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Kidney Cancer Therapeutics Market Share by Region: 2024 VS 2031
 Figure 17. Global Kidney Cancer Therapeutics Market Share by Players in 2024
 Figure 18. Global Top Kidney Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Therapeutics as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Therapeutics Revenue in 2024
 Figure 20. North America Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Kidney Cancer Therapeutics Market Share by Country (2020-2031)
 Figure 22. United States Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Kidney Cancer Therapeutics Market Share by Country (2020-2031)
 Figure 26. Germany Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Kidney Cancer Therapeutics Market Share by Region (2020-2031)
 Figure 34. China Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Kidney Cancer Therapeutics Market Share by Country (2020-2031)
 Figure 42. Mexico Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Kidney Cancer Therapeutics Market Share by Country (2020-2031)
 Figure 46. Turkey Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Kidney Cancer Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Merck Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 52. Pfizer Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 53. Roche Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 54. Amgen Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 55. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 56. Bayer Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 57. Exelixis Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 58. Eisai Revenue Growth Rate in Kidney Cancer Therapeutics Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Kidney Cancer or Renal Cancer Market Research Report 2024
Global Kidney Cancer Drugs Market Research Report 2024
Kidney Cancer Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Therapy Market Research Report 2024
Renal Cell Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer Therapeutics and Diagnostics Market Insights Forecast to 2030
Kidney Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Cancer and Renal Cell Carcinoma RCC Drugs Market Insights Forecast to 2030
Global Cancer Drug Therapy Market Insights Forecast to 2030
Global Renal Therapeutic Market Research Report 2025
Renal Cell Carcinoma Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Global Bladder Cancer Therapeutics and Diagnostics Market Research Report 2024
Global End Stage Renal Disease Market Research Report 2024
Global Kidney Cancer Market Research Report 2025
Global Kidney Cancer Molecular Diagnostics Market Research Report 2024
Global Kidney Cancer Targeted Therapy Market Research Report 2025
Global Kidney Chip Market Research Report 2024
Global Urological Cancer Therapeutics Drugs Market Research Report 2024
Global Prostate Cancer Diagnostics Market Research Report 2025

RELATED REPORTS

Global Fixation Device for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H16852
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Group A Streptococcus for Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K16619
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Boron Neutron Capture Therapy System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30U16301
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Radioactive Glass Microsphere Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2G16953
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions